Cellceutix begins Phase IIb clinical trial of Prurisol to treat psoriasis
US-based clinical stage biopharmaceutical company Cellceutix has begun its Phase IIb clinical trial of Prurisol to treat moderate-to-severe chronic plaque psoriasis.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Clinical Trials | Psoriasis